农药中间体
Search documents
雅本化学12月29日获融资买入349.34万元,融资余额2.33亿元
Xin Lang Cai Jing· 2025-12-30 01:34
截至12月20日,雅本化学股东户数5.31万,较上期减少1.43%;人均流通股17743股,较上期增加 1.45%。2025年1月-9月,雅本化学实现营业收入9.96亿元,同比增长6.00%;归母净利润-691.64万元, 同比增长87.81%。 分红方面,雅本化学A股上市后累计派现4.78亿元。近三年,累计派现9589.98万元。 12月29日,雅本化学跌0.59%,成交额4888.83万元。两融数据显示,当日雅本化学获融资买入额349.34 万元,融资偿还695.75万元,融资净买入-346.42万元。截至12月29日,雅本化学融资融券余额合计2.33 亿元。 融资方面,雅本化学当日融资买入349.34万元。当前融资余额2.33亿元,占流通市值的3.59%,融资余 额低于近一年40%分位水平,处于较低位。 融券方面,雅本化学12月29日融券偿还0.00股,融券卖出0.00股,按当日收盘价计算,卖出金额0.00 元;融券余量5.99万股,融券余额40.37万元,低于近一年20%分位水平,处于低位。 资料显示,雅本化学股份有限公司位于江苏省太仓市太仓港港口开发区石化区东方东路18号,成立日期 2006年1月1 ...
海利尔:公司主要从事农药制剂等的研发、生产和销售
Zheng Quan Ri Bao Zhi Sheng· 2025-12-29 11:46
(编辑 丛可心) 证券日报网讯 12月29日,海利尔在互动平台回答投资者提问时表示,公司主要从事农药制剂、农药中 间体、农药原药和功能性肥料的研发、生产和销售,未来公司持续聚焦主营业务发展,增强核心竞争能 力。 ...
雅本化学董事长蔡彤: 持续深化主业布局 推动核心业务迭代升级
Zheng Quan Shi Bao· 2025-12-17 19:16
近年来,雅本化学持续深化主业布局,推动核心业务迭代升级。在医药板块,公司重点发力创新药原料 药及中间体领域,与国内创新药龙头企业恒瑞医药(600276)签署战略合作协议,围绕肿瘤、代谢与心 血管疾病、免疫与呼吸系统疾病以及神经科学等重点领域,开展多维度、深层次合作,助力医药业务提 质增效。此外,雅本化学马耳他基地作为国际业务的桥头堡,具备欧盟GMP资质和制剂分装能力,可 为国内药企出海、拓展欧美等海外市场搭建桥梁;在农药中间体领域,公司聚焦绿色、高效、低毒的创 新农药CDMO业务,产品定制范围从农药中间体延伸至农药原药,与科迪华、拜耳、富美实等多家国际 农化企业保持战略合作,进一步巩固了在细分领域的领先地位。 此外,雅本化学还积极拓展大健康、新材料等业务,布局前沿高端赛道,形成"医药+农药+X"的主业格 局。"十四五"时期,雅本化学将技术创新作为核心发展引擎,累计斥资近6亿元用于研发投入,并率先 布局AI研发实验室,构建智能化研发体系。凭借突出的研发创新实力,公司不仅夯实了核心技术护城 河,更在行业内树立了科创型精细化工企业的鲜明标签。 蔡彤凭借在行业内的突出建树与社会层面的责任担当,收获各界高度认可。他曾斩 ...
*ST亚太:控股股东无条件豁免公司债务7500万元
Zhong Guo Zheng Quan Bao· 2025-12-10 01:50
本次债务豁免旨在妥善解决公司债务问题,提升公司持续经营能力。豁免生效后,广州万顺将不再要求 公司承担相关责任。公司表示,该事项不存在损害公司和全体股东利益的情形。 截至报告披露日,广州万顺合计持有公司16.40%的表决权股份。 *ST亚太主要从事精细化工产品中的农药中间体、医药中间体的研发、生产和销售。前三季度公司实现 营业总收入3.53亿元,同比增长1.20%。 中证智能财讯*ST亚太(000691)12月10日公告,为支持公司发展、减轻债务压力,公司控股股东广州 万顺技术有限公司决定单方面豁免公司债务本息合计7500万元。本次豁免为无条件、不可撤销,生效后 将相应增加公司资本公积7500万元。 ...
本立科技:盛孟均计划减持公司股份不超过约7.5万股
Mei Ri Jing Ji Xin Wen· 2025-12-09 11:42
每经AI快讯,本立科技(SZ 301065,收盘价:22.06元)12月9日晚间发布公告称,公司副总经理盛孟 均先生直接持有浙江本立科技股份有限公司股份30万股(占公司总股本的0.28%,占剔除公司回购专用 证券账户股份数量后总股本的比例为0.29%),通过台州少思投资合伙企业(有限合伙)(原名称为杭 州少思投资合伙企业(有限合伙),于2025年8月25日更名)间接持有公司股份约26万股(占公司总股 本的0.25%,占剔除公司回购专用证券账户股份数量后总股本的比例为0.25%);盛孟均先生拟在本公 告披露之日起15个交易日后的3个月内以集中竞价交易方式减持其直接持有的公司股份不超过约7.5万 股,占公司总股本的0.07%,占剔除公司回购专用证券账户股份数量后总股本的比例为0.07%。 2024年1至12月份,本立科技的营业收入构成为:医药中间体占比92.78%,农药中间体占比4.15%,其 他业务占比3.07%。 截至发稿,本立科技市值为23亿元。 每经头条(nbdtoutiao)——处方药变"瘾品":国内首次报告普瑞巴林滥用致成瘾病例,网络平台暴 露"无病历可购药"漏洞,列管与否尚需科学考量 (记者 王瀚黎 ...
华软科技跌2.05%,成交额1.91亿元,主力资金净流入3639.33万元
Xin Lang Zheng Quan· 2025-12-02 01:39
Group 1 - The core viewpoint of the news is that Huasoft Technology's stock has experienced fluctuations, with a year-to-date increase of 32.48% but a recent decline of 16.69% over the past five trading days [1] - As of December 2, Huasoft Technology's stock price is 6.69 yuan per share, with a total market capitalization of 5.435 billion yuan [1] - The company has seen a net inflow of main funds amounting to 36.39 million yuan, with significant buying and selling activity on December 1, where net buying was -12.71 million yuan [1] Group 2 - Huasoft Technology, established on January 13, 1999, and listed on July 20, 2010, is primarily engaged in the production and sales of computer software and hardware [2] - The company's main business revenue composition includes: 51.95% from AKD series paper chemicals, 17.24% from pharmaceutical and pesticide intermediates, 16.65% from fluorescent whitening agents, and 9.30% from electronic chemicals [2] - As of September 30, the number of shareholders has increased to 74,800, a rise of 67.77%, while the average circulating shares per person decreased by 40.40% [2] Group 3 - Huasoft Technology has distributed a total of 117 million yuan in dividends since its A-share listing, with no dividends paid in the last three years [3]
浙江巍华新材料股份有限公司 第五届董事会第二次会议决议公告
Zhong Guo Zheng Quan Bao - Zhong Zheng Wang· 2025-11-19 00:39
Group 1 - The company held its fifth board meeting on November 18, 2025, where all seven directors attended and voted on the agenda [2][5][3] - The board approved the acquisition of 70% equity in Jiangsu Heyutai Chemical Co., Ltd. for a cash consideration of 153.86 million yuan, funded by self-owned funds and bank loans [4][11][12] - The acquisition will allow Jiangsu Heyutai to become a wholly-owned subsidiary of the company, enhancing its product value chain and market position [11][15] Group 2 - Jiangsu Heyutai, established in June 2013, specializes in agricultural chemical products and has a registered capital of 120 million yuan [17][25] - The acquisition price was determined based on an asset appraisal that valued 100% of Jiangsu Heyutai's equity at 285.30 million yuan, with a 4.22% increase in value [28][30] - The company aims to leverage Jiangsu Heyutai's existing product lines and customer resources to enhance its operational efficiency and market reach [46][47] Group 3 - The transaction does not constitute a related party transaction or a major asset restructuring, and it does not require shareholder approval [12][16] - The company plans to implement measures to improve Jiangsu Heyutai's performance, which has shown signs of recovery after a period of losses [46][47] - The board's decision was supported by the strategic committee, ensuring compliance with legal and regulatory requirements [6][3]
华软科技11月17日获融资买入1964.59万元,融资余额2.61亿元
Xin Lang Cai Jing· 2025-11-18 01:28
Group 1 - The core viewpoint of the news is that Huasoft Technology has experienced significant changes in its financing and operational performance, with a notable decline in revenue and net profit [1][2]. - On November 17, Huasoft Technology's stock rose by 0.27%, with a trading volume of 360 million yuan. The financing buy-in amount was 19.65 million yuan, while the financing repayment was 37.68 million yuan, resulting in a net financing outflow of 18.04 million yuan [1]. - As of November 17, the total margin balance for Huasoft Technology was 261 million yuan, accounting for 5.50% of its market capitalization, indicating a high level of financing activity compared to the past year [1]. Group 2 - As of September 30, the number of shareholders for Huasoft Technology increased to 74,800, a rise of 67.77%, while the average circulating shares per person decreased by 40.40% to 8,191 shares [2]. - For the period from January to September 2025, Huasoft Technology reported a revenue of 261 million yuan, a year-on-year decrease of 38.93%, and a net profit attributable to the parent company of -12.5 million yuan, down 34.77% year-on-year [2]. - The company has cumulatively distributed 117 million yuan in dividends since its A-share listing, with no dividends distributed in the past three years [3].
分手费高达9.24亿元!善水科技实控人被抓后宣布离婚
Xi Niu Cai Jing· 2025-11-12 05:35
Core Viewpoint - Recently, Jiujiang Shanshui Technology Co., Ltd. announced the resolution of the marriage between its actual controller Huang Guorong and Wu Xinyan, along with arrangements regarding the division of shares [1]. Share Division - In the share division, 10 million shares directly held by Huang Guorong were transferred to Wu Xinyan. Additionally, Huang Guorong's indirect holdings included a property share of 21 million yuan (97.3123% of the partnership) and 6.9 million yuan (38.6685% of the partnership) which were also transferred to Wu Xinyan [2]. - Post-division, Huang Guorong directly holds 30 million shares of Shanshui Technology (13.9771% of total shares) and a total of 30.222 million shares (14.0806% of total shares). Wu Xinyan directly holds 35 million shares (16.3066% of total shares) and a total of 68.568 million shares (31.9461% of total shares) [2]. - Before the share division, Wu Xinyan held a total of 30.668 million shares, and after the division, she is expected to receive a total of 37.9 million shares. As of November 7, the closing price of Shanshui Technology was 24.38 yuan per share, valuing the shares Wu Xinyan will receive at approximately 924 million yuan [2]. - Wu Xinyan has become the actual controller and majority shareholder of Shanshui Technology, with a total voting power of 39.2114% [2]. Management Changes - On October 20, Shanshui Technology announced that Huang Guorong was subjected to criminal coercive measures due to personal reasons [3]. - On November 7, Huang Guorong submitted a written resignation report, stepping down from his positions as director, chairman, and general manager of the company due to personal reasons [5].
华软科技11月11日获融资买入1946.69万元,融资余额2.72亿元
Xin Lang Cai Jing· 2025-11-12 01:37
Group 1 - The core viewpoint of the news is that Huasoft Technology has experienced fluctuations in its financing activities and financial performance, indicating potential challenges in its business operations [1][2]. Group 2 - On November 11, Huasoft Technology's stock rose by 0.73%, with a trading volume of 222 million yuan. The financing buy-in amount was 19.47 million yuan, while the financing repayment was 20.08 million yuan, resulting in a net financing outflow of 0.61 million yuan [1]. - As of November 11, the total balance of margin trading for Huasoft Technology was 273 million yuan, with a financing balance of 272 million yuan, accounting for 6.15% of the circulating market value, which is above the 90th percentile level over the past year [1]. - The company had a margin repayment of 2,300 shares on November 11, with no shares sold short, resulting in a short balance of 32,890 yuan, which is above the 60th percentile level over the past year [1]. Group 3 - As of September 30, the number of shareholders for Huasoft Technology was 74,800, an increase of 67.77% compared to the previous period. The average circulating shares per person decreased by 40.40% to 8,191 shares [2]. - For the period from January to September 2025, Huasoft Technology reported operating revenue of 261 million yuan, a year-on-year decrease of 38.93%. The net profit attributable to the parent company was -125 million yuan, a year-on-year decrease of 34.77% [2]. Group 4 - Since its A-share listing, Huasoft Technology has distributed a total of 117 million yuan in dividends, with no dividends distributed in the past three years [3].